Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 38kWORD 17k
2 September 2019
E-002599-19
Question for written answer E-002599-19
to the Commission
Rule 138
Pascal Arimont (PPE)

 Subject:  Research into myalgic encephalomyelitis (ME)
 Answer in writing 

Chronic fatigue syndrome (CFS), or myalgic encephalomyelitis (ME), is a chronic condition that affects many people, but little is known about its precise causes.

To date, no recognised ways of properly diagnosing and treating the condition exist.

Does the EU provide funds for research into this condition so that diagnosis and treatment can be improved?

What practical steps is the EU taking to improve our knowledge of ME/CFS?

Original language of question: DE 
Last updated: 18 September 2019Legal notice